Cybin Corp is a mushroom life sciences company advancing psychedelic and nutraceutical-based products. The Company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the Company is structuring and supporting clinical studies across North America and other regions, through strategic academic and institutional partnerships.
Cybin's mission is to bring fungi derived psychedelic and medicinal products into the world that may potentially drive the next discovery phase of life changing medications to treat mental illness and other health conditions.
Cybin Corp is focused on furthering research and development of Psilocybin based medications through its wholly owned division, Serenity Life Sciences Inc. Psilocybin is found in certain species of mushrooms and is a non-habit forming naturally occurring psychedelic compound. Research is showing positive results for the treatment of depression, anxiety, PTSD, addictions, eating disorders, ADHD and other indications.
Their wholly owned division Natures Journey Inc operates the Journey™ brand and is focused on developing proprietary medicinal mushroom products that target mental wellness, immune boosting, detoxification and overall general health and wellness.